Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2009 1
2010 2
2011 4
2012 2
2013 2
2014 1
2015 1
2016 4
2017 3
2018 9
2019 10
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Results by year
Filters applied: . Clear all
Page 1
Cannabidiol (CBD) for Treatment of Neurofibromatosis-related Pain and Concomitant Mood Disorder: A Case Report.
Hegazy O, Platnick H. Hegazy O, et al. Cureus. 2019 Dec 6;11(12):e6312. doi: 10.7759/cureus.6312. Cureus. 2019. PMID: 31938604 Free PMC article.
Along with the chronic pain, psychosocial distress contributes to associated mood disorders, such as depression and anxiety. ...In this report, we present the use of cannabidiol (CBD) for the management of chronic pain and concomitant mood disorder
Along with the chronic pain, psychosocial distress contributes to associated mood disorders, such as depression and anxiety. . …
Cannabidiol (CBD) use in psychiatric disorders: A systematic review.
Bonaccorso S, Ricciardi A, Zangani C, Chiappini S, Schifano F. Bonaccorso S, et al. Neurotoxicology. 2019 Sep;74:282-298. doi: 10.1016/j.neuro.2019.08.002. Epub 2019 Aug 11. Neurotoxicology. 2019. PMID: 31412258 Review.
Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) are the most represented phytocannabinoids in Cannabis sativa plants. However, CBD may present with a different activity compared with the psychotomimetic THC. ...Eligible studies included randomized controlled trials (RC
Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) are the most represented phytocannabinoids in Cannabis sativa plants. However, CB
Cannabidiol in medical marijuana: Research vistas and potential opportunities.
Rong C, Lee Y, Carmona NE, Cha DS, Ragguett RM, Rosenblat JD, Mansur RB, Ho RC, McIntyre RS. Rong C, et al. Pharmacol Res. 2017 Jul;121:213-218. doi: 10.1016/j.phrs.2017.05.005. Epub 2017 May 10. Pharmacol Res. 2017. PMID: 28501518 Review.
Herein, we synthesize extant literature pertaining to the phytocannabinoid cannabidiol (CBD) and its brain effects. The principle phytocannabinoid Δ(9)-tetrahydrocannabinol (Δ(9)-THC) and CBD are the major pharmacologically active cannabinoids. ...Cannabidiol is wit …
Herein, we synthesize extant literature pertaining to the phytocannabinoid cannabidiol (CBD) and its brain effects. The principle phy …
Review of the neurological benefits of phytocannabinoids.
Maroon J, Bost J. Maroon J, et al. Surg Neurol Int. 2018 Apr 26;9:91. doi: 10.4103/sni.sni_45_18. eCollection 2018. Surg Neurol Int. 2018. PMID: 29770251 Free PMC article. Review.
The phytocannabinoids, cannabidiol (CBD), and delta-9-tetrahydrocannabinol (Δ9-THC) are the most studied extracts from cannabis sativa subspecies hemp and marijuana. ...In addition, psychiatric and mood disorders, such as schizophrenia, anxiety, depression, a …
The phytocannabinoids, cannabidiol (CBD), and delta-9-tetrahydrocannabinol (Δ9-THC) are the most studied extracts from cannabis sativ …
Cannabis and Mood Disorders.
Lucatch AM, Coles AS, Hill KP, George TP. Lucatch AM, et al. Curr Addict Rep. 2018 Sep;5(3):336-345. doi: 10.1007/s40429-018-0214-y. Epub 2018 May 10. Curr Addict Rep. 2018. PMID: 30643708 Free PMC article.
PURPOSE OF REVIEW: The present review will provide an overview of the neurobiology, epidemiology, clinical impact, and treatment of cannabis use disorder (CUD) in mood disorders. RECENT FINDINGS: Patients with mood disorders including major depr …
PURPOSE OF REVIEW: The present review will provide an overview of the neurobiology, epidemiology, clinical impact, and treatment of cannabis …
Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa.
de Mello Schier AR, de Oliveira Ribeiro NP, Coutinho DS, Machado S, Arias-Carrión O, Crippa JA, Zuardi AW, Nardi AE, Silva AC. de Mello Schier AR, et al. CNS Neurol Disord Drug Targets. 2014;13(6):953-60. doi: 10.2174/1871527313666140612114838. CNS Neurol Disord Drug Targets. 2014. PMID: 24923339 Review.
Cannabidiol (CBD) is a constituent non-psychotomimetic of Cannabis sativa with great psychiatric potential, including uses as an antidepressant-like and anxiolytic-like compound. ...Studies involving animal models, performing a variety of experiments on the above-mentioned
Cannabidiol (CBD) is a constituent non-psychotomimetic of Cannabis sativa with great psychiatric potential, including uses as an anti
Endocannabinoid system dysfunction in mood and related disorders.
Ashton CH, Moore PB. Ashton CH, et al. Acta Psychiatr Scand. 2011 Oct;124(4):250-61. doi: 10.1111/j.1600-0447.2011.01687.x. Epub 2011 Mar 9. Acta Psychiatr Scand. 2011. PMID: 21916860 Review.
It is involved in mood and related disorders, and its activity may be modified by exogenous cannabinoids. This article examines the therapeutic potential of cannabinoids in psychiatric disorders. ...Anandamide, tetrahydrocannabinol (THC) and cannabidiol
It is involved in mood and related disorders, and its activity may be modified by exogenous cannabinoids. This article examine …
Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review.
Turna J, Syan SK, Frey BN, Rush B, Costello MJ, Weiss M, MacKillop J. Turna J, et al. Alcohol Clin Exp Res. 2019 Apr;43(4):550-563. doi: 10.1111/acer.13964. Epub 2019 Feb 19. Alcohol Clin Exp Res. 2019. PMID: 30698831 Free PMC article.
There is substantial interest in the therapeutic potential of cannabidiol (CBD), a nonpsychoactive cannabinoid found in plants of the genus Cannabis. The goal of the current systematic review was to characterize the existing literature on this topic and to evaluate the cre …
There is substantial interest in the therapeutic potential of cannabidiol (CBD), a nonpsychoactive cannabinoid found in plants of the …
Drug-drug interactions as a result of co-administering Δ9-THC and CBD with other psychotropic agents.
Rong C, Carmona NE, Lee YL, Ragguett RM, Pan Z, Rosenblat JD, Subramaniapillai M, Shekotikhina M, Almatham F, Alageel A, Mansur R, Ho RC, McIntyre RS. Rong C, et al. Expert Opin Drug Saf. 2018 Jan;17(1):51-54. doi: 10.1080/14740338.2017.1397128. Epub 2017 Oct 31. Expert Opin Drug Saf. 2018. PMID: 29082802 Review.
The search term cannabis was cross-referenced with the terms drug interactions, cytochrome, cannabinoids, cannabidiol, and medical marijuana. Pharmacological, molecular, and physiologic studies evaluating the pharmacokinetics of Δ(9)-tetrahydrocannabinol (Δ(9)-THC) and …
The search term cannabis was cross-referenced with the terms drug interactions, cytochrome, cannabinoids, cannabidiol, and medical ma …
Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels.
Sales AJ, Crestani CC, Guimarães FS, Joca SRL. Sales AJ, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Aug 30;86:255-261. doi: 10.1016/j.pnpbp.2018.06.002. Epub 2018 Jun 6. Prog Neuropsychopharmacol Biol Psychiatry. 2018. PMID: 29885468
Cannabidiol (CBD) is a compound of Cannabis sativa with relevant therapeutic potential in several neuropsychiatric disorders including depression. ...
Cannabidiol (CBD) is a compound of Cannabis sativa with relevant therapeutic potential in several neuropsychiatric disorders i
42 results
Jump to page
Feedback